TJ08
TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.
Product Specifications
CAS Number
2924274-19-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
405.38
Molecular Formula
C22H16FN3O4
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog